Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity

Nature Reviews Immunology

Volumn 8, Issue 6, 2008, Pages 478-486

  Galli, Stephen J ^a   Grimbaldeston, Michele ^a,b   Tsai, Mindy ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HANSON INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTACT ALLERGY; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; MAST CELLS;

EID: 44349101991     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2327     Document Type: Review

References (94)

1. Galli, S. J. et al. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786 (2005).
2. Mekori, Y. A. & Metcalfe, D. D. Mast cells in innate immunity. Immunol. Rev. 173, 131-140 (2000).
3. Dawicki, W. & Marshall, J. S. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 19, 31-38 (2007).
4. Gilfillan, A. M. & Tkaczyk, C. Integrated signalling pathways for mast-cell activation. Nature Rev. Immunol. 6, 218-230 (2006).
5. Grimbaldeston, M. A., Metz, M., Yu, M., Tsai, M. & Galli, S. J. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr. Opin. Immunol. 18, 751-760 (2006).
6. Sayed, B. A., Christy, A., Quirion, M. R. & Brown, M. A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 26, 705-739 (2008).
7. Malaviya, R. & Abraham, S. N. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179, 16-24 (2001).
8. Maurer, M. et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512-516 (2004).
9. Metz, M. et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 313, 526-530 (2006).
10. Piliponsky, A. M. et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nature Med. 14, 392-398 (2008).
11. Schneider, L. A., Schlenner, S. M., Feyerabend, T. B., Wunderlin, M. & Rodewald, H. R. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J. Exp. Med. 204, 2629-2639 (2007).
12. Boyce, J. A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 217, 168-185 (2007).
13. Galli, S. J., Nakae, S. & Tsai, M. Mast cells in the development of adaptive immune responses. Nature Immunol. 6, 135-142 (2005).
14. Mills, K. H. Regulatory T cells: friend or foe in immunity to infection? Nature Rev. Immunol. 4, 841-855 (2004).
15. Kitamura, Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59-76 (1989).
16. Metcalfe, D. D., Baram, D. & Mekori, Y. A. Mast cells. Physiol. Rev. 77, 1033-1079 (1997).
17. Kawakami, T. & Galli, S. J. Regulation of mast-cell and basophil function and survival by IgE. Nature Rev. Immunol. 2, 773-786 (2002).
18. Ryan, J. J. et al. Mast cell homeostasis: a fundamental aspect of allergic disease. Crit. Rev. Immunol. 27, 15-32 (2007).
19. Miller, H. R., Wright, S. H., Knight, P. A. & Thornton, E. M. A novel function for transforming growth factor-β1: upregulation of the expression and the IgE-dependent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1. Blood 93, 3473-3486 (1999).
20. Blank, U. & Rivera, J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25, 266-273 (2004).
21. Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P. & Kalogeromitros, D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 217, 65-78 (2007).
22. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167, 835-848 (2005).
23. Grimbaldeston, M. A., Nakae, S., Kalesnikoff, J., Tsai, M. & Galli, S. J. Mast cell-derived interleukin-10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunol. 8, 1095-1104 (2007).
24. (W-sh) mice does not impair antibody-mediated arthritis. J. Exp. Med. 204, 2797-2802 (2007).
25. v. J. Cell. Physiol. 73, 25-30 (1969).
26. Wastling, J. M. et al. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the β-chymase, mouse mast cell protease-1. Am. J. Pathol. 153, 491-504 (1998).
27. Knight, P. A., Wright, S. H., Lawrence, C. E., Paterson, Y. Y. & Miller, H. R. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192, 1849-1856 (2000).
28. Lawrence, C. E., Paterson, Y. Y., Wright, S. H., Knight, P. A. & Miller, H. R. Mouse mast cell protease-1 is required for the enteropathy induced by gastrointestinal helminth infection in the mouse. Gastroenterology 127, 155-165 (2004).
29. Tchougounova, E., Pejler, G. & Abrink, M. The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J. Exp. Med. 198, 423-431 (2003).
30. Pejler, G., Abrink, M., Ringvall, M. & Wernersson, S. Mast cell proteases. Adv. Immunol. 95, 167-255 (2007).
31. McNeil, H. P., Adachi, R. & Stevens, R. L. Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J. Biol. Chem. 282, 20785-20789 (2007).
32. Thakurdas, S. M. et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J. Biol. Chem. 282, 20809-20815 (2007).
33. Shin, K. et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J. Immunol. 180, 4885-4891 (2008).
34. Feyerabend, T. B. et al. Loss of histochemical identity in mast cells lacking carboxypeptidase A. Mol. Cell. Biol. 25, 6199-6210 (2005).
35. Scholten, J. et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgen. Res. 17, 307-315 (2008).
36. Newlands, G. F., Miller, H. R., MacKellar, A. & Galli, S. J. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N. brasiliensis infection. Blood 86, 1968-1976 (1995).
37. Brandt, E. B. et al. Mast cells are required for experimental oral allergen-induced diarrhea. J. Clin. Invest. 112, 1666-1677 (2003).
38. Gekara, N. O. & Weiss, S. Mast cells initiate early anti-Listeria host defences. Cell Microbiol. 10, 225-236 (2008).
39. Soucek, L. et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nature Med. 13, 1211-1218 (2007).
40. Sun, J. et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117, 3359-3368 (2007).
41. Arumugam, T., Ramachandran, V. & Logsdon, C. D. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J. Natl Cancer Inst. 98, 1806-1818 (2006).
42. Norris, A. A. Pharmacology of sodium cromoglycate. Clin. Exp. Allergy 26 (Suppl. 4), 5-7 (1996).
43. Mekori, Y. A. & Metcalfe, D. D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104, 517-523 (1999).
44. Skokos, D. et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 166, 868-876 (2001).
45. Kambayashi, T. et al. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 111, 1489-1496 (2008).
46. Kashiwakura, J., Yokoi, H., Saito, H. & Okayama, Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173, 5247-5257 (2004).
47. Nakae, S. et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176, 2238-2248 (2006).
48. Frandji, P. et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151, 6318-6328 (1993).
49. Hart, P. H. et al. Dermal mast cells determine susceptibility to ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in mice. J. Exp. Med. 187, 2045-2053 (1998).
50. Jutel, M. et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425 (2001).
51. Nakae, S. et al. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc. Natl Acad. Sci. USA 102, 6467-6472 (2005).
52. H2 cells. J. Immunol. 175, 6531-6536 (2005).
53. H2 polarized immune responses in vivo. Immunobiology 211, 463-472 (2006).
54. H1 responses in EAE. J. Clin. Invest. 116, 1327-1336 (2006).
55. Caughey, G. H. Mast cell tryptases and chymases in inflammation and host defense. Immunol. Rev. 217, 141-154 (2007).
56. Stevens, R. L. & Adachi, R. Protease-proteoglycan complexes of mouse and human mast cells and importance of their β-tryptase-heparin complexes in inflammation and innate immunity. Immunol. Rev. 217, 155-167 (2007).
57. Wershil, B. K., Wang, Z. S., Gordon, J. R. & Galli, S. J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J. Clin. Invest. 87, 446-453 (1991).
58. Zhang, Y., Ramos, B. F. & Jakschik, B. A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258, 1957-1959 (1992).
59. Malaviya, R., Ikeda, T., Ross, E. & Abraham, S. N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381, 77-80 (1996).
60. Biedermann, T. et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441-1452 (2000).
61. Malaviya, R. & Abraham, S. N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67, 841-846 (2000).
62. Demeure, C. E. et al. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J. Immunol. 174, 3932-3940 (2005).
63. Kakurai, M. et al. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am. J. Pathol. 169, 1713-1721 (2006).
64. Maurer, M. et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. Faseb J. 20, 2460-2467 (2006).
65. Suto, H. et al. Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176, 4102-4112 (2006).
66. Nigrovic, P. A. et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc. Natl Acad. Sci. USA 104, 2325-2330 (2007).
67. H2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120, 48-55 (2007).
68. H17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 109, 3640-3648 (2007).
69. Siebenhaar, F. et al. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am. J. Pathol. 170, 1910-1916 (2007).
70. Reuter, S. et al. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur. Respir. J. 31, 773-782 (2008).
71. Jawdat, D. M., Albert, E. J., Rowden, G., Haidl, I. D. & Marshall, J. S. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173, 5275-5282 (2004).
72. McLachlan, J. B. et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nature Immunol. 4, 1199-1205 (2003).
73. Echtenacher, B., Mannel, D. N. & Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (1996).
74. Maurer, M. et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188, 2343-2348 (1998).
75. Supajatura, V. et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109, 1351-1359 (2002).
76. Orinska, Z. et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nature Med. 13, 927-934 (2007).
77. Matsuda, H. et al. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J. Immunol. 144, 259-262 (1990).
78. Robbie-Ryan, M., Tanzola, M. B., Secor, V. H. & Brown, M. A. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170, 1630-1634 (2003).
79. Kim, Y. S. et al. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-α in a murine model of asthma. Eur. J. Immunol. 37, 1107-1115 (2007).
80. Lee, D. M. et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689-1692 (2002).
81. Chen, R. et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108, 1151-1158 (2001).
82. Depinay, N., Hacini, F., Beghdadi, W., Peronet, R. & Mecheri, S. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J. Immunol. 176, 4141-4146 (2006).
83. Lu, L. F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002 (2006).
84. - precursor cells in the absence of interleukin 10. Nature Immunol. 8, 931-941 (2007).
85. Beissert, S., Schwarz, A. & Schwarz, T. Regulatory T cells. J. Invest. Dermatol. 126, 15-24 (2006).
86. H1 cells control themselves by producing interleukin-10. Nature Rev. Immunol. 7, 425-428 (2007).
87. d mast cell-deficient mice. J. Immunol. 131, 2687-2694 (1983).
88. Bryce, P. J. et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20, 381-392 (2004).
89. Eder, W., Ege, M. J. & von Mutius, E. The asthma epidemic. N. Engl. J. Med. 355, 2226-2235 (2006).
90. McLachlan, J. B. et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nature Med. 20 April 2008 (doi: 10.1038/nm1757).
91. Larché, M., Akdis, C. A. & Valenta, R. Immunological mechanisms of allergen-specific immunotherapy. Nature Rev. Immunol. 6, 761-771 (2006).
92. Woolhiser, M. R., Okayama, Y., Gilfillan, A. M. & Metcalfe, D. D. IgG-dependent activation of human mast cells following up-regulation of FcγRI by IFN-γ. Eur. J. Immunol. 31, 3298-3307 (2001).
93. Jawdat, D. M., Rowden, G. & Marshall, J. S. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J. Immunol. 177, 1755-1762 (2006).
94. Hochegger, K. et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur. J. Immunol. 35, 3074-3082 (2005).